You have 9 free searches left this month | for more free features.

pf-05221304

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NASH (Nonalcoholic Steatohepatitis), NAFLD (Nonalcoholic Fatty Liver Disease) Trial (PF-05221304, Placebo)

Withdrawn
  • NASH (Nonalcoholic Steatohepatitis)
  • NAFLD (Nonalcoholic Fatty Liver Disease)
  • PF-05221304
  • Placebo
  • (no location specified)
Aug 19, 2021

Hepatic Impairment Trial in Worldwide (PF-05221304)

Completed
  • Hepatic Impairment
  • PF-05221304
  • Orlando, Florida
  • +5 more
Jun 19, 2019

Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in Worldwide (Placebo, PF-05221304)

Completed
  • Nonalcoholic Fatty Liver Disease
  • Nonalcoholic Steatohepatitis
  • Placebo
  • PF-05221304
  • Bakersfield, California
  • +139 more
Dec 7, 2020

Healthy Trial in Hachioji-shi (PF-05221304, Placebo)

Completed
  • Healthy
  • PF-05221304
  • Placebo
  • Hachioji-shi, Tokyo, Japan
    P-one Clinic, Keikokai Medical Corporation
Nov 26, 2018

Normal Healthy Trial in New Haven (PF-05221304, Placebo)

Completed
  • Normal Healthy
  • PF-05221304
  • Placebo
  • New Haven, Connecticut
    New Haven Clinical Research Unit
May 22, 2018